Insider Cluster (2 insiders) ·Filed Sep 11, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed20d 7h ago
Insider cluster: 2 insiders, $1.6M total
Actionable Insight • Neutral

The CEO's sales are mechanically tied to option exercises and represent a tiny fraction of market cap. The $477.6M ASR is the more material event — it signals management's view that shares are undervalued and will mechanically reduce share count by ~1.5M shares (assuming ~$320 avg buyback price). Monitor Q4 2026 final settlement for actual share retirement. No bearish read-through from insider sales.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
UTHR ▼ -0.50% at T+5d
NEUTRAL call ✗ call lost -0.50% · α vs SPY -0.28% · entry $497.11 → $494.63
Next anchor: T+20d in 6d
Latest observation: T+13 +7.92% FF3 residual α
Entry anchored
Sep 10, 06:19 PM ET
via 1-min bar
T+1d
+1.12%
call +1.12% · α +1.57%
$502.70
settled 21d ago
T+5d
-0.50%
call -0.50% · α -0.28%
$494.63
settled 15d ago
T+20d
—
call — · α —
—
in 6d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt sold ~$6.9M in open-market shares on Sep 9-10, 2026, while simultaneously exercising stock options. General Counsel Paul Mahon sold $740K on Sep 3. The cluster follows a $477.6M accelerated share repurchase agreement announced Sep 8. Total open-market sales of ~$7.6M represent ~0.04% of UTHR's $21.3B market cap — trivial in proportion. The sales appear liquidity-driven (option exercise cash-out) rather than a bearish signal, consistent with the weak predictive power of insider sales clusters per academic literature.

Key Financial Metrics

Direction
selling
Total Value
$7.6M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold 12,917 open-market shares totaling ~$6.9M on Sep 9-10, 2026
  • CEO simultaneously exercised 28,500 stock options (19,000 at $117.76, 9,500 at $0)
  • General Counsel Paul Mahon sold 1,500 shares for $740K on Sep 3, 2026
  • Company announced $477.6M accelerated share repurchase agreement with Citi on Sep 8, 2026
  • Total open-market sales of ~$7.6M represent ~0.04% of $21.3B market cap

Financial Impact

Total insider open-market sales of ~$7.6M vs $21.3B market cap (0.04%) — immaterial

dilutioninsider ownership

Risk Factors

  • CEO sold ~$6.9M even after a $477.6M buyback announcement — could signal personal diversification needs or a muted view on near-term upside
  • ASR exposes company to mark-to-market risk if stock rises during the averaging period, potentially reducing share count less than expected

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1789192954962
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 12, 2026